NJ Bio, Inc.’s Post

View organization page for NJ Bio, Inc., graphic

14,809 followers

Discover the latest developments in the ever-evolving ADC landscape! The updated May version of our downloadable PDF is now available on our website. Stay updated and make informed choices for your ADC programs. Download now: https://lnkd.in/ervRAr4B #ADC #DrugDevelopment #Research #CancerTherapy

  • No alternative text description for this image
Ravi Chari

Biotechnology Consultant at RChari Consulting.Medicinal Chemistry | Patents | Antibody-Drug Conjugates (ADCs).

1mo

This is an excellent resource- very comprehensive and up to date. Highly recommended!

Achutha Madhankumar

Experienced Scientist in Therapeutics Development

1mo

Interesting document providing comprehensive information on the chemistry, mechanism of action, and adverse effects of ADCs

Like
Reply
Narayana Murthy Sekar

MOLWAY Stands for Innovation

4w

Thanks Dr, it is a good report.

Like
Reply
Sochan Rumthao, Ph.D.

Motivated, resourceful, scientific and technical leader with Productivity, Quality, Safety mindsets and business intelligence.

1mo

Thank you Naresh for sharing! This lit is helpful. Appreciate it very much.

Like
Reply
Sachin Kawade, Ph.D.

Carbohydrates| Medicinal Chemistry| Antibody Drug Conjugate| Bio-conjugation| Molecular biology| Microarray| Bio-sensors| API |

1mo

Interesting... Thank you for sharing

Like
Reply
Jeffrey Yang, Pharm.D., Ph.D.

Synthetic Organic and Medicinal Chemist | Passionate Drug Discovery R&D and CMC Leader | Small Molecule Design & Synthesis | Antibody-Drug Conjugates | New Chemical Modalities and Technologies

1mo

Appreciate the continual updates and sharing of this open access resource. Great work! 👏

Like
Reply
Sachindra Patil

MD and CSO at Kanashi Biotech Pvt Ltd

3w

Thanks for sharing! Very interesting information and insight. 

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics